Will cellular immunotherapies end neurodegenerative diseases?

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Neurodegenerative disorders pose significant global health challenges, compounded by aging populations and limited treatment options.
• Neuroinflammation is a common feature across diverse neurodegenerative diseases.
• The traditional view implicates the immune system as a driver of neurodegeneration, but emerging evidence suggests a more complex role.

Purpose of the Study:

• To challenge the prevailing dogma regarding the immune system's role in neurodegeneration.
• To propose a novel therapeutic strategy for neurodegenerative diseases based on immune system modulation.
• To reframe neuroinflammation not just as a destructive process but as a potentially reparative one.

Main Methods:

• Conceptual analysis and reinterpretation of existing evidence on neuroinflammation.
• Analogy drawn from road construction to illustrate the dual nature of immune responses in the central nervous system (CNS).
• Proposal of cellular immunotherapies as a means to coordinate immune responses for therapeutic benefit.

Main Results:

• Evidence suggests that immune system actions in the CNS, while appearing disruptive, may aim to combat neurodegeneration.
• The immune response, akin to construction, can cause temporary harm while undertaking essential repair processes.
• A paradigm shift is proposed, viewing immune responses as potentially beneficial when properly directed.

Conclusions:

• The role of the immune system in neurodegeneration may be more nuanced than previously understood.
• Cellular immunotherapies offer a promising approach to harness and redirect the immune system for CNS repair.
• This perspective opens new avenues for developing treatments for neurodegenerative diseases by focusing on immune-mediated remodeling.